INMEVA, SUSPENSION FOR INJECTION
INMEVA, SUSPENSION FOR INJECTION
Authorised
- Chlamydia abortus, strain A22, Inactivated
- Salmonella enterica, subsp. enterica, serovar Abortusovis, strain Sao, Inactivated
Product identification
Medicine name:
INMEVA, SUSPENSION FOR INJECTION
Inmeva Suspensie voor injectie
Inmeva Suspension injectable
Inmeva Injektionssuspension
Active substance:
- Chlamydia abortus, strain A22, Inactivated
- Salmonella enterica, subsp. enterica, serovar Abortusovis, strain Sao, Inactivated
Target species:
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Chlamydia abortus, strain A22, Inactivated1.00relative potency1.00unit(s)
-
Salmonella enterica, subsp. enterica, serovar Abortusovis, strain Sao, Inactivated1.00relative potency1.00unit(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Sheep
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Polyethylene (PET) vials of 10ml
- Polyethylene (PET) vials of 250ml
- Polyethylene (PET) vials of 100ml
- Polyethylene (PET) vials of 50ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V543155
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0350/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: